1 |
Voronkova KV, Alieva AM, Nikitin IG, Musina GM, Surskaya EV, Zaitseva OS, Mashkevich NG, Gomonova LV, Petrukhin AS. [The role of the phenosanic acid in the combined treatment of patients with epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova 2023;123:151-7. [PMID: 36843473 DOI: 10.17116/jnevro2023123021151] [Reference Citation Analysis]
|
2 |
Ponomareva IV, Stepanova SB, Reneva SA, Sorokova EV, Vagina MA, Makodzeba OA, Galiullin TR. [Possibilities of optimizing therapy in COVID-19 survivors with focal epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova 2023;123:130-6. [PMID: 36946409 DOI: 10.17116/jnevro2023123031130] [Reference Citation Analysis]
|
3 |
Karlina MV, Kosman VM, Makarov VG, Makarova MN, Morozov SV, Gushchina EE, Zhuravskaya NV. Pharmacokinetic Interactions of Phenosanic Acid with Valproic Acid and Carbamazepine in Dogs. Bezopasnost' i risk farmakoterapii 2022;10:420-433. [DOI: 10.30895/2312-7821-2022-10-4-420-433] [Reference Citation Analysis]
|
4 |
Nikitin E, Mironova E, Shpakovsky D, Gracheva Y, Koshelev D, Utochnikova V, Lyssenko K, Oprunenko Y, Yakovlev D, Litvinov R, Seryogina M, Spasov A, Milaeva E. Cytotoxic and Luminescent Properties of Novel Organotin Complexes with Chelating Antioxidant Ligand. Molecules 2022;27. [PMID: 36500450 DOI: 10.3390/molecules27238359] [Reference Citation Analysis]
|
5 |
Kosman VM, Karlina MV, Tyutina KV, Makarov VG, Makarova MN, Morozov SV, Gushchina EE, Zhuravskaya NV. Preclinical study of pharmacokinetic ADME processes of phenosanic acid <i>in vitro</i> and <i>in vivo</i>. Rev Clin Pharm Drug Ther 2022;20:297-308. [DOI: 10.17816/rcf203297-308] [Reference Citation Analysis]
|